NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews today reported that its fourth-quarter 2008 revenues increased 72 percent, while its net loss rose slightly on increased R&D spending.

The Toronto-based firm brought in revenues of C$536,626 (US$423,628) for the three-month period ended Dec. 31, 2008, compared to C$312,314 for the fourth quarter of 2007. Its revenues were largely the result of milestone payments received from an Asian biomedical consortium for research on prostate disease biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.